E-LIB Suche - Ergebnisse für: Gleeson, John P

1

Validation of a Caco-2 microfluidic Chip model for predicti..:

Zhang, Stephanie Y. ; Ong, Whitney S.Y. ; Subelzu, Natalia.
International Journal of Pharmaceutics. 656 (2024) - p. 124089 , 2024

Link: https://doi.org/10.1016/..

2

Head-to-Head Comparison of Caco-2 Transwell and Gut-on-a-Ch..:

Gleeson, John P. ; Zhang, Stephanie Y. ; Subelzu, Natalia...
Molecular Pharmaceutics. , 2024

Link: https://doi.org/10.1021/..

3

Physiologically Based Pharmacokinetic (PBPK) Modeling Appli..:

, In: AAPS Introductions in the Pharmaceutical Sciences; Advances in Pharmacokinetics and Pharmacodynamics,

Wu, Di ; Gleeson, John P. ; Kesisoglou, Filippos - p. 29-56 , 2023

Link: https://doi.org/10.1007/..

4

An Innovative miR‐Activated Scaffold for the Delivery of a ..:

Intini, Claudio ; Ferreras, Lia Blokpoel ; Casey, Sarah...
Advanced Therapeutics. 6 (2023) 7 - p. , 2023

Link: https://doi.org/10.1002/..

5

Intestinal permeation enhancers enable oral delivery of mac..:

Fein, Katherine C. ; Gleeson, John P. ; Newby, Alexandra N..
European Journal of Pharmaceutics and Biopharmaceutics. 170 (2022) - p. 70-76 , 2022

Link: https://doi.org/10.1016/..

6

Long‐term daily oral administration of intestinal permeatio..:

Fein, Katherine C. ; Gleeson, John P. ; Cochran, Kyle...
Bioengineering & Translational Medicine. 8 (2022) 1 - p. , 2022

Link: https://doi.org/10.1002/..

7

A highly porous type II collagen containing scaffold for th..:

Intini, Claudio ; Lemoine, Mark ; Hodgkinson, Tom...
Biomaterials Science. 10 (2022) 4 - p. 970-983 , 2022

Link: https://doi.org/10.1039/..

8

Highly Porous Type II Collagen-Containing Scaffolds for Enh..:

Intini, Claudio ; Hodgkinson, Tom ; Casey, Sarah M...
Bioengineering. 9 (2022) 6 - p. 232 , 2022

Link: https://doi.org/10.3390/..

9

The strawberry-derived permeation enhancer pelargonidin ena..:

Lamson, Nicholas G. ; Fein, Katherine C. ; Gleeson, John P....
Proceedings of the National Academy of Sciences. 119 (2022) 33 - p. , 2022

Link: https://doi.org/10.1073/..

10

Formulation, Characterisation and Evaluation of the Antihyp..:

Khalid Danish, Minna ; Gleeson, John P. ; Brayden, David J....
International Journal of Molecular Sciences. 23 (2022) 19 - p. 11160 , 2022

Link: https://doi.org/10.3390/..

11

The enhanced intestinal permeability of infant mice enables..:

Gleeson, John P. ; Fein, Katherine C. ; Chaudhary, Namit...
International Journal of Pharmaceutics. 593 (2021) - p. 120120 , 2021

Link: https://doi.org/10.1016/..

12

Oral delivery of peptide therapeutics in infants: Challenge..:

Gleeson, John P. ; Fein, Katherine C. ; Whitehead, Kathryn A.
Advanced Drug Delivery Reviews. 173 (2021) - p. 112-124 , 2021

Link: https://doi.org/10.1016/..

13

Development of Physiologically Responsive Human iPSC-Derive..:

Gleeson, John P. ; Estrada, Hannah Q. ; Yamashita, Michifumi...
International Journal of Molecular Sciences. 21 (2020) 4 - p. 1438 , 2020

Link: https://doi.org/10.3390/..

14

Growth Hormone Induces Colon DNA Damage Independent of IGF-:

Chesnokova, Vera ; Zonis, Svetlana ; Barrett, Robert J..
Endocrinology. 160 (2019) 6 - p. 1439-1447 , 2019

Link: https://doi.org/10.1210/..

15

Sa1096 – A Personalized Model to Assess Intestinal Permeabi..:

Gleeson, John P. ; Rabizadeh, Shervin ; Estrada, Hannah Q....
Gastroenterology. 156 (2019) 6 - p. S-269-S-270 , 2019

Link: https://doi.org/10.1016/..